A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...

Summer and all the running, jumping and playing does not have a corner on the market of finding a bruise on your body when ...

A patient and provider share updates on pelabresib plus Rituxan treatment, which met the MANIFEST-2 trial's primary end point ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

BeiGene, Ltd. , a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...

The Business Research Company's Global Blood Platelets Market Outlook 2025–2034: Drivers, Trends, Growth Opportunities & Forecast Analysis LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 / ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

The Global Coagulation Monitoring Products Market is expected to reach at a CAGR of 5.6% during the forecast period 2025-2033. The Coagulation Monitoring Products Market is growing due to rising ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Why is the COVID vaccine for pregnant women in the news? Robert F. Kennedy Jr., secretary of health and human services – the ...